MedTrace Logo

To Assess the Effect of Naproxcinod Versus Naproxen and Ibuprofen on Arterial Blood Pressure in Osteoarthritis Patients With Controlled Essential Hypertension

NCT00662896 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2011-06-17

No results posted yet for this study

Summary

To assess the effect of naproxcinod vs. naproxen and ibuprofen on arterial blood pressure in patients with osteoarthritis and controlled essential hypertension

Conditions

Interventions

DRUG

naproxcinod 375 mg bid

naproxcinod 375 mg bid

DRUG

naproxcinod 750 mg bid

naproxcinod 750 mg bid

DRUG

naproxen 250 mg bid

naproxen 250 mg bid

DRUG

naproxen 500 mg bid

naproxen 500 mg bid

DRUG

ibuprofen 600 mg tid

ibuprofen 600 mg tid

Sponsors & Collaborators

  • NicOx

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2008-09-30
Completion
2008-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00662896 on ClinicalTrials.gov